Lumonus筹集2 500万澳元,在全球扩大AI-动力癌症护理工具。 Lumonus raises A$25 million to expand AI-powered cancer care tools globally.

一家AI保健技术公司Lumonus获得了2 500万澳元的B系列资金,以扩大其由AI驱动的全球肿瘤工作流程,目的是将自动化纳入癌症护理进程,提高治疗规划和病人管理的效率。 Lumonus, an AI health tech company, has secured A$25 million in Series B funding to expand its AI-driven oncology workflows worldwide, aiming to integrate automation into cancer care processes and improve efficiency in treatment planning and patient management.